Related references
Note: Only part of the references are listed.Plasma β-amyloid1-42 reference values in cognitively normal subjects
Chiara Zecca et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2018)
The Physiological Roles of Amyloid-beta Peptide Hint at New Ways to Treat Alzheimer's Disease
Holly M. Brothers et al.
FRONTIERS IN AGING NEUROSCIENCE (2018)
Salivary beta amyloid protein levels are detectable and differentiate patients with Alzheimer's disease dementia from normal controls: preliminary findings
Marwan N. Sabbagh et al.
BMC NEUROLOGY (2018)
Immunochemical Methods in Health Risk Assessment: Cross Reactivity of Antibodies against Mycotoxin Deoxynivalenol with Deoxynivalenol-3-glucoside
Jiří Ruprich et al.
Central European Journal of Public Health (2018)
Making the final cut: pathogenic amyloid-β peptide generation by γ-secretase
Harald Steiner et al.
CELL STRESS (2018)
A Method for Diagnosing Alzheimer's Disease Based on Salivary Amyloid-β Protein 42 Levels
Moonhee Lee et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Levels of amyloid-beta-42 and CSF pressure are directly related in patients with Alzheimer's disease
Tommaso Schirinzi et al.
JOURNAL OF NEURAL TRANSMISSION (2017)
Analytical Performance of ELISA Assays in Urine: One More Bottleneck towards Biomarker Validation and Clinical Implementation
Despina Chatziharalambous et al.
PLOS ONE (2016)
Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer's disease
Yang Xiang et al.
ACTA NEUROPATHOLOGICA (2015)
A general protocol for the generation of Nanobodies for structural biology
Els Pardon et al.
NATURE PROTOCOLS (2014)
Nanobody-based products as research and diagnostic tools
Thomas De Meyer et al.
TRENDS IN BIOTECHNOLOGY (2014)
What causes Alzheimer's disease?
Richard A. Armstrong
FOLIA NEUROPATHOLOGICA (2013)
Enzyme Immunoassay and Enzyme-Linked Immunosorbent Assay
Stephanie D. Gan et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Plasma amyloid beta measurements - a desired but elusive Alzheimer's disease biomarker
Jon B. Toledo et al.
ALZHEIMERS RESEARCH & THERAPY (2013)
Brain Imaging in Alzheimer Disease
Keith A. Johnson et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
The ELISA guidebook
G. Ya. Wiederschain
BIOCHEMISTRY-MOSCOW (2009)
Detection of amyloid β protein in the urine of Alzheimer's disease patients and healthy individuals
Manabu Takata et al.
NEUROSCIENCE LETTERS (2008)
Soluble protein oligomers in neurodegeneration:: lessons from the Alzheimer's amyloid β-peptide
Christian Haass et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Monoclonal versus polyclonal antibodies: Distinguishing characteristics, applications, and information resources
NS Lipman et al.
ILAR JOURNAL (2005)
Partly nonparametric approach for determining the limit of detection
K Linnet et al.
CLINICAL CHEMISTRY (2004)
Domain antibodies: proteins for therapy
LJ Holt et al.
TRENDS IN BIOTECHNOLOGY (2003)
Amyloidosis and Alzheimer's disease
J Ghiso et al.
ADVANCED DRUG DELIVERY REVIEWS (2002)
Share Paper
